CheckMyRecalls

Exela Pharma Sciences LLC recalls .4% Sodium Bicarbonate Injection

Published
2 Apr 2025
Units affected
103,950 vials
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4

Brand / company
Exela Pharma Sciences LLC
Codes / lots
Lots: 10006417 and 10006418, Exp. 11/30/2026
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 2 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.